VCAM1 and atherosclerosis: Park et al. developed mAbs against VCAM-1 (H6 and 7H) via phage display and found success in inhibiting atherosclerosis in vivo using a traditional apolipoprotein-E–deficient (ApoE−/−) atherosclerosis murine model.